Entry stagePre-seed, Seed, Series A, Series B
Check sizen/a
Leads roundsYes
FocusLife sciences, Healthtech
Latest fund$2B AUM
Investing team20 peopleNo activity since Sep
Who you would pitch at Catalio Capital Management
20 people on the investing team, 9 of them partners who can make the call. Partners are listed first.
George C. PetrocheilosCo-Founder & Managing PartnerHe previously was a General Partner at Camden Partners Holdings, LLC.
R. Jacob Vogelstein, Ph.D.Co-Founder & Managing PartnerHe previously was a General Partner at Camden Partners and served on the faculty at Johns Hopkins University.
Ajay ManthaPartnerHe previously held roles at Zimmer Partners, Bain Capital, D.E.
Ben SnedekerPartner & Head of Public EquitiesHe previously held roles at HealthCor Management, PointState Capital, D.E.
Diamantis Xylas, M.D.Partner & Head of ResearchHe previously trained in surgery and researched at Weill Cornell.
Hai Yan, Ph.D.PartnerHe is also a professor at A*STAR and co-founded Genetron Health.
Isaac RoPartnerHe previously held CFO roles at Sema4 and Thrive Earlier Detection, and led equity research at Goldman Sachs.
John Henry Iucker, CFAPartner & Head of CreditFocus: structured credit for healthcare and biotech firms.
Tom BrooksPartnerHe previously held executive roles at Constellation Energy Group and worked at Goldman Sachs.
Matthew Hobson, Ph.D.PrincipalFocus: therapeutics and diagnostics investments.
Nicholas von Guionneau, M.D.PrincipalHe focuses on breakthrough medical technologies and clinical care delivery, and holds board observer roles at several companies.
Pasquale ChiacchiariPrincipal & Head of Data ScienceFocus: data science and AI in healthcare investments.
Sean WangPrincipalHe previously held roles at Oaktree, Ares, Athyrium, and Guggenheim.
Vicky SostilioVice President, North AmericaShe previously led investor relations at HealthCor Management and worked at UBS.
Will DenehyVice President, EuropeHe previously held roles at Odey Asset Management and Fisher Investments.
Brian Malik, Ph.D.Senior AnalystHe previously held roles at T.
Collin Spencer, Ph.D.AssociateFocus: AI-enabled healthcare investments.
Constantine AlexosAnalystHe previously worked in healthcare investment banking at Goldman, Sachs & Co. and holds a finance degree from Indiana University.
David Stonko, M.D.Clinical Associate
Trent MurphyAnalyst
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Before you pitch
Ownership target7-10%
How to reach them[email protected]
Notable investments
ArriVent BioPharmaDianthus TherapeuticsNeumora TherapeuticsCompass PathwaysPaige
In their words
Catalio Capital ManagementCatalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Cawww.cataliocapital.com
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Catalio Capital Management is active
One email when this firm shows new activity. Nothing else.
Firms like Catalio Capital Management
On these lists
Seed healthtech investors in New York47Series A healthtech investors in New York39Pre-seed healthtech investors in New York29Seed life sciences investors in New York26Series A life sciences investors in New York26Series B healthtech investors in New York22Series B life sciences investors in New York20Pre-seed life sciences investors in New York15
Questions
What stage does Catalio Capital Management invest in?
Catalio Capital Management reports entry at pre-seed, seed, series a, series b.
How much does Catalio Capital Management invest?
Catalio Capital Management has not reported a check size.
Does Catalio Capital Management lead rounds?
Yes. Catalio Capital Management says it can lead.
Who are the partners at Catalio Capital Management?
George C. Petrocheilos (Co-Founder & Managing Partner), R. Jacob Vogelstein, Ph.D. (Co-Founder & Managing Partner), Ajay Mantha (Partner), Ben Snedeker (Partner & Head of Public Equities), Diamantis Xylas, M.D. (Partner & Head of Research), Hai Yan, Ph.D. (Partner).
Is Catalio Capital Management active right now?
No recent activity since September 2026.
Work at Catalio Capital Management? Claim or correct this profile.